Selenium for preventing cancer.

Findings

This major review of 10 randomized controlled trials involving over 27,000 people found that selenium supplements did not reduce cancer risk. In fact, the data showed no meaningful difference between people taking selenium and those taking a placebo—the summary risk ratio was 1.01, meaning selenium supplements were essentially neutral for cancer prevention.

Design
Meta-Analysis
Sample
n=232
Evidence
Strong
Journal
The Cochrane database of systematic reviews
Ingredients studied